These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30145830)

  • 1. LPS promotes the expression of PD-L1 in gastric cancer cells through NF-κB activation.
    Li H; Xia JQ; Zhu FS; Xi ZH; Pan CY; Gu LM; Tian YZ
    J Cell Biochem; 2018 Dec; 119(12):9997-10004. PubMed ID: 30145830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of NF-κB is required for oleanolic acid to downregulate PD-L1 by promoting DNA demethylation in gastric cancer cells.
    Lu X; Li Y; Yang W; Tao M; Dai Y; Xu J; Xu Q
    J Biochem Mol Toxicol; 2021 Jan; 35(1):e22621. PubMed ID: 32894642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut-derived lipopolysaccharide remodels tumoral microenvironment and synergizes with PD-L1 checkpoint blockade via TLR4/MyD88/AKT/NF-κB pathway in pancreatic cancer.
    Yin H; Pu N; Chen Q; Zhang J; Zhao G; Xu X; Wang D; Kuang T; Jin D; Lou W; Wu W
    Cell Death Dis; 2021 Oct; 12(11):1033. PubMed ID: 34718325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells.
    Wang X; Yang L; Huang F; Zhang Q; Liu S; Ma L; You Z
    Immunol Lett; 2017 Apr; 184():7-14. PubMed ID: 28223102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy inhibition enhances PD-L1 expression in gastric cancer.
    Wang X; Wu WKK; Gao J; Li Z; Dong B; Lin X; Li Y; Li Y; Gong J; Qi C; Peng Z; Yu J; Shen L
    J Exp Clin Cancer Res; 2019 Mar; 38(1):140. PubMed ID: 30925913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-940 promotes the proliferation and migration of gastric cancer cells through up-regulation of programmed death ligand-1 expression.
    Fan Y; Che X; Hou K; Zhang M; Wen T; Qu X; Liu Y
    Exp Cell Res; 2018 Dec; 373(1-2):180-187. PubMed ID: 30367831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type Iγ phosphatidylinositol phosphate kinase regulates PD-L1 expression by activating NF-κB.
    Xue J; Chen C; Qi M; Huang Y; Wang L; Gao Y; Dong H; Ling K
    Oncotarget; 2017 Jun; 8(26):42414-42427. PubMed ID: 28465490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-ɑ signaling.
    Ju X; Zhang H; Zhou Z; Chen M; Wang Q
    Exp Cell Res; 2020 Nov; 396(2):112315. PubMed ID: 33031808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein Expression of Programmed Death 1 Ligand 1 and HER2 in Gastric Carcinoma.
    Oki E; Okano S; Saeki H; Umemoto Y; Teraishi K; Nakaji Y; Ando K; Zaitsu Y; Yamashita N; Sugiyama M; Nakashima Y; Ohgaki K; Oda Y; Maehara Y
    Oncology; 2017; 93(6):387-394. PubMed ID: 28910818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
    BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-1 and PD-L1 Up-regulation Promotes T-cell Apoptosis in Gastric Adenocarcinoma.
    Chiu YM; Tsai CL; Kao JT; Hsieh CT; Shieh DC; Lee YJ; Tsay GJ; Cheng KS; Wu YY
    Anticancer Res; 2018 Apr; 38(4):2069-2078. PubMed ID: 29599324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Associated Fibroblast-Derived IL-8 Upregulates PD-L1 Expression in Gastric Cancer Through the NF-κB Pathway.
    Lou M; Iwatsuki M; Wu X; Zhang W; Matsumoto C; Baba H
    Ann Surg Oncol; 2024 May; 31(5):2983-2995. PubMed ID: 38006530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death-ligand 1 is a promising blood marker for predicting tumor progression and prognosis in patients with gastric cancer.
    Amatatsu M; Arigami T; Uenosono Y; Yanagita S; Uchikado Y; Kijima Y; Kurahara H; Kita Y; Mori S; Sasaki K; Omoto I; Maemura K; Ishigami S; Natsugoe S
    Cancer Sci; 2018 Mar; 109(3):814-820. PubMed ID: 29345842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
    Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
    World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
    Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
    J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of PD-L1 Expression by NF-κB in Cancer.
    Antonangeli F; Natalini A; Garassino MC; Sica A; Santoni A; Di Rosa F
    Front Immunol; 2020; 11():584626. PubMed ID: 33324403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactions.
    Sasaki S; Nishikawa J; Sakai K; Iizasa H; Yoshiyama H; Yanagihara M; Shuto T; Shimokuri K; Kanda T; Suehiro Y; Yamasaki T; Sakaida I
    Gastric Cancer; 2019 May; 22(3):486-496. PubMed ID: 30264329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of PD-L1 Transcriptional Regulation in Ovarian Cancer Cells by Chromatin Immunoprecipitation.
    Zou Y; Padmanabhan S; Vancurova I
    Methods Mol Biol; 2020; 2108():229-239. PubMed ID: 31939185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection.
    Wu YY; Lin CW; Cheng KS; Lin C; Wang YM; Lin IT; Chou YH; Hsu PN
    Clin Exp Immunol; 2010 Sep; 161(3):551-9. PubMed ID: 20646001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer.
    Bouillez A; Rajabi H; Jin C; Samur M; Tagde A; Alam M; Hiraki M; Maeda T; Hu X; Adeegbe D; Kharbanda S; Wong KK; Kufe D
    Oncogene; 2017 Jul; 36(28):4037-4046. PubMed ID: 28288138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.